Immuno Technologies

Immuno Technologies

TN - Memphis
Diagnostics4 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Vaccines, Monoclonal Antibodies, Diagnostics

Immuno Technologies is a life sciences company focused on Vaccines, Monoclonal Antibodies, Diagnostics.

Infectious DiseasesVaccines
Funding Stage
PUBLIC
Open Jobs
0

Products & Portfolio (1)

GIAPREZA
angiotensin ii
Peak
INTRAVENOUS · SOLUTION
12.1. Mechanism of Action Angiotensin II raises blood pressure by vasoconstriction and increased aldosterone release. Direct action of angiotensin II on the vessel wall is mediated by binding to the G-protein-coupled angiotensin II receptor type 1 on vascular smooth muscle cells, which stimulates Ca/calmodulin-dependent phosphorylation of myosin and causes smooth muscle contraction.
2017
0

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2014
Portfolio: 1 approved product
Top TAs: Cardiovascular
H-1B (2023): 4 approvals
Portfolio Health
Peak1 (100%)
1 total products
Therapeutic Area Focus
Cardiovascular
1 marketed
Marketed
Pipeline

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
4
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub